You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 8,057,818


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,057,818
Title:Methods of making expandable foam-like biomaterials
Abstract: Liquid, injectable, aqueous solutions are transformed in situ to an expandable foam-like, space filling, and adherent biomaterial. Preferably, the foam-like biomaterial is the reaction product of a two-part liquid system to achieve the in situ formation thereof. The liquid system is generally comprised of a protein solution and a cross linker solution which may either be premixed and then applied to a site in need of the biomaterial, or simultaneously mixed and delivered through an in-line mixing/dispensing tip directly to the site. In especially preferred embodiments, an expandable foam-like biomaterial includes the reaction product of human or animal-derived protein material and a di- or polyaldehyde in the presence of a bicarbonate and an acidic titrant amounts sufficient to impart a cellular foam structure to the material.
Inventor(s): Yuksel; K. Umit (Kennesaw, GA), Bird; Ana T. (Achworth, GA), Black; Kirby S. (Achworth, GA)
Assignee: CryoLife, Inc. (Kennesaw, GA)
Application Number:11/042,181
Patent Claims:1. A method of making a biopolymeric material having a cellular foam structure comprising: combining a proteinaceous pre-polymeric liquid material and a cross linker solution to produce a mixture, wherein the proteinaceous pre-polymeric liquid material comprises a water soluble or plasma protein; introducing or producing a gaseous blowing agent into the proteinaceous pre-polymeric liquid material or the mixture; and allowing the mixture to cross-link and solidify simultaneously with the introduction or production of the gaseous blowing agent to thereby form the biopolymeric material having a cellular foam structure.

2. The method of claim 1, wherein the proteinaceous pre-polymeric liquid material comprises an aqueous solution of human or animal-derived protein material and the cross linker solution comprises an aqueous solution of a di- or polyaldehyde.

3. The method of claim 2, wherein the aqueous solution of human or animal-derived protein material further comprises a bicarbonate and the aqueous solution of said di- or polyaldehyde further comprises an acidic titrant.

4. The method of claim 2 or 3, wherein the biopolymeric material has a volume which is greater than combined volumes of the aqueous solutions.

5. The method of claim 2, wherein the aqueous solution of human or animal-derived protein material is neutral or slightly alkaline.

6. The method of claim 5, wherein the aqueous solution of di- or polyaldehyde is acidic.

7. The method of claim 2, wherein the human or animal-derived protein material comprises albumin.

8. The method of claim 7, wherein the human or animal-derived protein material comprises serum albumin.

9. The method of claim 2, wherein the aqueous solution of a di- or polyaldehyde comprises glutaraldehyde.

10. The method of claim 1, wherein the biopolymeric material is adhesive to human or animal tissue.

11. The method of claim 1, wherein the step of combining comprises: expelling the proteinaceous pre-polymeric liquid material from a first chamber and expelling the cross linker solution from a second chamber, and passing the expelled materials into a mixing tip comprising static mixing elements that cause the proteinaceous pre-polymeric liquid material and the cross linker solution to combine to form the mixture.

12. A method of making a biopolymeric material having a cellular foam structure comprising: combining a proteinaceous pre-polymeric liquid material and an aqueous solution of a di- or polyaldehyde to produce a mixture; introducing or producing a gaseous blowing agent into the mixture; and then allowing the mixture to solidify to thereby form the biopolymeric material having a cellular foam structure, wherein the biopolymeric material has a volume which is greater than the sum of the volumes of the proteinaceous pre-polymeric liquid material and aqueous solution.

13. The method of claim 12, wherein the biopolymeric material is adhesive to human or animal tissue.

14. The method of claim 12, wherein the proteinaceous pre-polymeric liquid material comprises human or bovine serum albumin.

15. The method of claim 12, wherein the aqueous solution of a di- or polyaldehyde comprises glutaraldehyde.

16. A method of making a biopolymeric material having a cellular foam structure comprising: preparing a two-part mixture which comprises a Part A and a Part B, wherein the Part A includes an aqueous solution of a human- or animal-derived protein material and a bicarbonate compound, and the Part B includes an aqueous solution of a di- or polyaldehyde and a titrant, and wherein the bicarbonate compound and the titrant react to evolve a gas into the two-part mixture; and allowing the two-part mixture to react and solidify, thereby forming a biopolymeric material having a cellular foam structure which has a volume that is greater than the sum of the volumes of the aqueous solutions of Parts A and B.

17. The method of claim 16, wherein the bicarbonate compound comprises sodium bicarbonate, potassium bicarbonate, or ammonium bicarbonate.

18. The method of claim 16, wherein the titrant comprises phosphoric acid, sulfuric acid, hydrochloric acid, citric acid, or acetic acid.

19. The method of claim 16, wherein the human- or animal-derived protein material comprises albumin.

20. The method of claim 19, wherein the albumin is human or bovine serum albumin.

21. The method of claim 16, wherein the di- or polyaldehyde comprises a glutaraldehyde.

22. A foam biomaterial comprising: a human- or animal-derived plasma or water-soluble protein material crosslinked with a di- or polyaldehyde, wherein the di- or polyaldehyde comprises glutaraldehyde, wherein the biomaterial comprises a solid cellular foam structure comprising albumin, and wherein the foam biomaterial is sterilized.

23. The biomaterial of claim 22, which is made by the method of claim 2.

24. The biomaterial of claim 22, wherein the albumin comprises human or bovine serum albumin.

25. The biomaterial of claim 22, wherein the cellular foam structure comprises both open and closed cells.

26. The biomaterial of claim 22, which is adhesive to human or animal tissue.

Details for Patent 8,057,818

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 10/21/1942 ⤷  Try a Trial 2020-11-07
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 03/03/1954 ⤷  Try a Trial 2020-11-07
Csl Behring Ag ALBURX albumin (human) Injection 102366 07/23/1976 ⤷  Try a Trial 2020-11-07
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.